Shunji Tomatsu
Papers
2
Total Citations
60
H-Index
2
About
Shunji Tomatsu is a leading expert in the diagnosis and treatment of mucopolysaccharidoses (MPS), a family of devastating lysosomal storage disorders. His research focuses on developing novel screening and monitoring technologies to improve outcomes for children with these rare genetic diseases. Dr. Tomatsu’s major contributions include pioneering the use of automated high-throughput mass spectrometry for the precise quantification of heparan sulfate, a key biomarker for MPS. His landmark 2014 paper on this assay, cited over 36 times, established a new standard for non-invasive disease monitoring and newborn screening. He further advanced the field by applying tandem mass spectrometry to newborn screening protocols, enabling earlier diagnosis and intervention for MPS patients. His work has been instrumental in translating cutting-edge analytical chemistry into clinical practice, directly impacting the lives of affected children and their families. Dr. Tomatsu’s research bridges the critical gap between laboratory innovation and patient care, making him a pivotal figure in the fight against these debilitating disorders.
Research Focus
Key Achievements
Top Papers
- 1
- 2